We performed a randomised double-blind pilot study in 16 healthy volunteers to investigate the success rate for placing a new suture-method catheter for sciatic nerve block. A catheter was inserted into both legs of volunteers and each was randomly allocated to receive 15 ml lidocaine 2% through the catheter in one leg and 15 ml saline in the other leg. Successful placement of the catheter was defined as a 20% decrease in maximum voluntary isometric contraction for dorsiflexion of the ankle. Secondary outcomes were maximum voluntary isometric contraction for plantar flexion at the ankle, surface electromyography and cold sensation. After return of motor and sensory function, volunteers performed standardised physical exercises; injection of the same study medication was repeated in the same leg and followed by motor and sensory assessments. Fifteen of 16 (94%; 95%CI 72-99%) initial catheter placements were successful. The reduction in maximum voluntary isometric contraction and surface electromyography affected the peroneal nerve more often than the tibial nerve. Eleven of 15 (73%; 95%CI 54-96%) catheters remained functional with motor and sensory block after physical exercise, and the maximal displacement was 5 mm. Catheters with secondary block failure were displaced between 6 and 10 mm. One catheter was displaced 1.8 mm that resulted in a decrease in maximum voluntary isometric contraction of less than 20%. After repeat test injection, 14 of the 16 volunteers had loss of cold sensation. Neither motor nor sensory functions were affected in the legs injected with placebo. We conclude that the suture-method catheter can be placed with a high success rate, but that physical exercise may cause displacement.
Introduction
Preventing postoperative pain is important because severe pain results in increased morbidity and mortality [1] . Approximately 240 million patients undergo surgery every year with a significant proportion experiencing pain [2, 3] . A multi-modal approach is often used for treatment of postoperative pain using a combination of systemic and regional analgesics. For example, the addition of peripheral nerve blocks provides superior postoperative analgesia after orthopaedic surgery [4] , and the use of continuous peripheral nerve block (CPNB) techniques can prolong the duration of regional analgesia resulting in less pain and reduced opioid consumption [5] .
The implementation of CPNB in the clinical setting is inconsistent [6] despite superior clinical effects on pain and patient satisfaction [7, 8] . This may be due to the perceived technically demanding and time-consuming insertion procedure for CPNB. After successful placement of a catheter, there is a subsequent risk of displacement resulting in catheter failure [9, 10] . Recent studies have reported displacement rates as high as 40-50% for popliteal sciatic nerve catheters [11, 12] .
A new catheter with a suture-method design has been developed and cadaver studies suggest high success rates for initial placement. This new catheter is a 'catheter-and-needle-in-one' and consists of three parts: a needle, a catheter and a detachable hub (Fig. 1) . The needle is curved and connected to a 19-G nylon catheter and the device therefore resembles a suture. The detachable hub covers the connection between needle and catheter and serves as a handle when the needle is advanced. The hub has two channels: one channel holds the catheter and the other allows hydro-dissection through the needle tip during insertion. The section of the catheter closest to the needle is filled by alternating regions of glue and air in order to increase echogenicity. The distal section of the catheter has a lumen that extends to a Luer lock injection port. Two exit holes are placed opposite each other at the transition between the interrupted section and the lumen of the catheter (Fig. 2) .
The name 'suture-method' refers to the technique used for insertion. The needle is advanced assisted by hydro-dissection under ultrasound guidance, aiming for spread around the intended nerve. Then, the needle is advanced beyond the nerve to exit the skin on the other side of the nerve. The catheter is pulled through, leaving the catheter orifices in close approximation to the target nerve using ultrasound visualisation with concurrent confirmation of circumferential spread around the nerve with injection through the catheter (Figs. 2 and 3 ). The catheter is fixed to the skin surface at both the entrance and exit site. This enables repositioning of the catheter if displacement occurs [13, 14] . We decided to investigate the success rate for Figure 1 The suture-method catheter. Left: The suture-catheter device. N, needle; H, hub; and C, catheter. Right: The suture-method catheter during insertion. The needle has been inserted past the nerve to exit the skin on the other side of the nerve. placement of the new suture-method catheter for sciatic nerve block, as well as the block failure rate due to displacement after a series of standardised physical exercises in healthy volunteers.
Methods
Following approval from the Regional Research Ethics Committee, the Danish Medicines Agency and the Danish Data Protection Agency, we recruited healthy volunteers through a national recruitment website (sundhed.dk) sanctioned by the Danish Ministry of Health. Volunteers received payment for participation and gave their written informed consent before enrolment. The Good Clinical Practice Unit at The Copenhagen University Hospital monitored the trial. The study took place at Nordsjaellands Hospital, Denmark between April and June 2015. Volunteers were eligible if they were ≥ 18 years of age and were of ASA physical status 1 or 2. Exclusion criteria were body mass index (BMI) ≥ 30 kg.m À2 ; previous surgery involving the area to be investigated; pain or other disability of the investigated region resulting in sensory or neurological deficit; allergy to local anaesthetics; and pregnancy, breastfeeding or an unwillingness to practise birth control during participation in the study.
The following baseline values for both legs were obtained before catheter insertion: maximum voluntary isometric contraction (MVIC) for dorsiflexion and plantar flexion at the ankle; surface electromyography (sEMG) from the anterior tibial muscle and the lateral and medial heads of the gastrocnemius muscle; and cold sensation to touch with a cold glass vial stored at 5°C. All volunteers had bilateral suture-method catheters (Certa Catheter TM , Ferrosan Medical Devices, Szczecin, Poland) with a curvature radius of 75 mm and a length of 160 mm inserted at the level of the bifurcation of the sciatic nerve. With volunteers in the prone position, the bifurcation of the sciatic nerve was identified in the popliteal fossa using ultrasound (Flex Focus 500 system with an 8870 transducer, BK Medical, Analogic Ultrasound Group, Peabody, MA, USA). Using a short-axis view, the suture-method catheter was inserted in-plane in a lateral-to-medial trajectory below the biceps muscle. We performed hydro- In this illustration, the needle is passed superficial to the nerve, and the catheter orifices can be pulled through to the desired locations.
dissection using saline to assist with needle positioning. Depending on the anatomy, we placed the needle above the nerve, below the nerve or between the tibial and common peroneal nerve components, to obtain the most favourable trajectory within the common neural sheath. We advanced the needle beyond the nerves to exit the skin medially. We positioned the local anaesthetic delivery orifice by pulling on either end of the catheter using ultrasound guidance. The position was further confirmed with ultrasound visualisation of saline spread around the nerve after injection through the catheter (Video S1). A maximum of 10 ml saline was used for hydro-dissection and initial placement. Two investigators (C and TL) performed all the catheter insertions. Further technical details regarding the suture-method catheter insertion technique have been published previously [14] . All the catheters were secured with either Tegaderm TM dressings (3M Healthcare, Copenhagen, Denmark) at both ends, or the occluded end was additionally secured between two Tegaderm TM intravenous dressings in a 'sandwich' fashion and covered with a further Tegaderm dressing.
Using computer-generated randomisation software (randomization.com), each volunteer was then randomly allocated to receive 15 ml lidocaine 2% through the catheter in one leg and 15 ml saline through the catheter in the other leg. Thirty minutes following the injections, motor and sensory functions were tested, and again at intervals of 30 min until return of maximum voluntary isometric contraction (MVIC) within 10% of baseline values and the return of normal sensation. The volunteers then performed a series of physical exercises with 20 repetitions consisting of the following: 1) lying supine with legs stretched, active knee flexion was performed while keeping the heel in contact with the bed, until the lower leg was vertical; 2) sitting on the bed with legs hanging over the edge, each leg was extended to become horizontal and then returned; 3) while standing, the volunteers performed hip flexion and full knee flexion (170°) of each leg; 4) standing, the volunteers abducted to 45°and adducted 20°in the hip joint; and 5) walking up and down two flights of stairs. After the physical exercises, the catheter position was assessed using ultrasound before a second injection of study medication. To allow estimation of block failures due to displacement, the position of displaced catheters was not adjusted and each leg was injected with the same study medication as that used for the initial injection. Motor and sensory functions were tested 30 min after the second injections.
The primary outcome was successful initial placement, defined as a 20% decrease in MVIC for dorsiflexion of the ankle 30 min after local anaesthetic injection compared with baseline. Secondary outcomes were the difference in cold sensation at 30 min after first and second injection of local anaesthetic compared with baseline; the difference in sEMG activity 30 min after the first injection compared with baseline; difference in MVIC for plantar flexion 30 min after the first and second injections compared with baseline; difference in MVIC for dorsiflexion of the ankle 30 min after the second injection and baseline; and displacement of catheter orifice in millimetres, assessed by ultrasound at initial placement and before the second injection.
Maximum voluntary isometric contraction was measured using a dynamometer (SAEHAN Digital Hand Held Dynamometer DHD-1, MSD Europe, Belgium) which was fixed to a wooden board secured to the bed. We measured sEMG (Biometrics Ltd., Datalink DLK900, Newport, UK) during MVIC [15] . Maximum voluntary isometric contraction for dorsiflexion and sEMG from the anterior tibial muscle were measured with the volunteers lying supine. The foot was fixed to the dynamometer in a neutral position with a strap placed over the mid-foot and around the dynamometer handle. The strap was tightened with an allowance of up to 5-kg force before active muscle contraction. This allowance was subtracted from the maximal force development to obtain MVIC.
Maximum voluntary isometric contraction for plantar flexion with concomitant sEMG from the two heads of the gastrocnemius muscle were measured in the same manner but with the volunteers sitting in an upright position with the hip joint flexed and knees extended. Furthermore, the wooden board and dynamometer was fixed with a strap around the elevated part of the bed to prevent movement of the dynamometer due to the greater application of force from the gastrocnemius muscles. Results for MVIC and sEMG were taken as an average of three consecutive measurements one minute apart in order to minimise the potential for random differences. For the peroneal component, cold sensation was a priori defined to be measured on the skin, four finger widths below the fibular head, using a cold glass vial stored at 5°C. Catheter displacement was assessed by measuring distance from the catheter orifice position at the time of initial placement to the catheter orifice position after physical exercises (Fig. 4) .
Personnel not involved in the study created the randomisation list and prepared consecutively numbered sealed opaque envelopes that were opened after placement of the catheters. The study medication was prepared in identical syringes according to randomisation and marked with 'left' or 'right' by a registered nurse who was not part of the study group. The volunteers and the investigators responsible for the initial catheter placement were also blinded as to randomisation and were not involved in later assessments. After baseline measurements, the outcome assessors were divided into two groups responsible for either the assessments after the first or the second injection. All outcome assessors were blinded as to randomisation and insertion and were only present for baseline measurements and their allocated assessment.
The primary outcome of a 20% reduction in MVIC from baseline as an indication of motor weakness was chosen because the standard deviation (SD) for MVIC dorsiflexion in healthy individuals is 6.3-9.6% (depending on dominance) [16] . Thus, assuming a normal distribution, an MVIC value is 95% likely to be within mean AE 2 SD. A difference of more than 2 SD in MVIC dorsiflexion is considered highly unlikely if no other parameters are modified or influence the performance of MVIC (p < 0.05). On this basis, we chose to interpret a reduction of more than 2 SD as an indicator of successful block. We assumed that primary placement would be successful in at least 90% of cases and required a sample size that could establish a lower limit for the 95% confidence interval (CI) above 70%. Normal approximation methods for calculating 95%CI are imprecise with small sample sizes and when the proportion is close to 0 or 1. For a more precise 95% CI estimation, we used the Wilson interval method [17] . Thus, we calculated that 16 volunteers were needed, allowing for a 10% dropout rate. We used SPSS (IBM SPSS Statistics, version 22.0.0; IBM Corp, Armonk, New York, USA) software for statistical analyses and considered a p value < 0.05 to be significant.
Results
A CONSORT flow diagram shows the 16 volunteers included in this study (Fig. 5) . Baseline volunteer characteristics are shown in Table 1 . In 15 out of 16 catheters (94%; 95%CI 72-99%) injected with local anaesthetic, initial placements were successful with MVIC reductions of more than 20% compared with baseline (range 0-63% of baseline). One catheter failed due to a reduction in MVIC of less than 20%, although it was assessed sonographically to be correctly positioned with satisfactory spread around the sciatic nerve both at initial insertion and after repeat injection by the investigators. All 16 volunteers had loss of cold sensation over the skin supplied by the peroneal nerve. The peroneal nerve was more often affected than the tibial nerve when assessing reduction in motor function and sEMG activity ( Table 2) . Assessment of block failure due to displacement was performed for the remaining 15 participants who had a primary successful placement. Eleven out of 15 (73%; 95%CI 54-96%) catheters remained functional with both motor and sensory block following physical exercise. The maximal displacement was 5 mm for these catheters as assessed by ultrasound during the second injection of local anaesthetic. Three of the four catheters with block failure due to displacement were displaced by between 6 and 10 mm. One catheter was displaced by 1.8 mm and this was associated with altered sensation but less than a 20% decrease in MVIC. A second injection of local anaesthetic resulted in loss of cold sensation in 14 out of 16 volunteers. In the 16 catheters injected with saline in the placebo group, there was no effect on motor or sensory function. Fourteen out of 16 catheters in this group were displaced between 0 mm and 5.5 mm. The two remaining catheters were displaced 12.4 mm and 35 mm. Estimation of block failure and relation to displacement distance was inherently not possible in the placebo group.
Discussion
In this randomised double-blind pilot study, we found a success rate of 94% for initial placement of the suture-method catheter for sciatic nerve block, which is similar to the success rates for single injection techniques (76-90%) [18] [19] [20] . However, while the other studies also tested for block success 30 min after injection, they used a higher volume of local anaesthetic (30 ml) than we have used and employed sensory block to define success. After primary placement and resolution of the initial block, volunteers in our study performed vigorous exercise causing 27% of catheters to displace, as defined as a decrease in MVIC by > 20%. This may be superior to other studies that reported a displacement rate of 40-50% of sciatic catheters when placed perpendicular to the nerve [11, 12] . Some studies have reported fewer displacements but they did not systematically assess catheter position or function [21] [22] [23] , whereas others consistently tested for catheter function by using loss of cold sensation [24] . By comparison, we found loss of cold sensation corresponding to dermatomes of the common peroneal nerve in 14 out of 16 catheters (88%) after physical exercises and repeat local anaesthetic injection. Although onset of motor block has been reported to take longer than the onset of sensory block, both types of block may potentially develop more than 30 min after injection of shortacting drugs [25] [26] [27] . Thus, a higher success rate for initial placement and a lower secondary failure rate may be theoretically possible had we tested at a later time-point. The low volumes of local anaesthetic used in this study might increase the possibility of failed block due to imprecise primary placement or Figure 5 CONSORT flow diagram of volunteers included in the study. secondary displacement. However, despite using a lower volume than previous studies using ultrasoundguided placement of sciatic catheters (20-40 ml) [11, 18, 22, 25, [28] [29] [30] [31] , we still achieved a high success rate.
Other potential advantages of the suture-method design include the curved needle that may improve needle/probe angle, thereby augmenting needle visualisation. Needle tip manoeuvrability is also enhanced compared with a straight needle. The echogenic design of the catheter with alternating air and glue enables precise placement and adjustment by pulling on either end of the catheter. The suture-method catheter passes through more tissue with resulting tissue damage. However, real-time ultrasound guidance permits continuous needle tip visualisation and may help to minimise the risk of unintentional tissue injury.
There are several considerations unique to the suture-method catheter. Both needle entry and exit points, as well as trajectory, need to be evaluated before catheter insertion. Concerns might be raised regarding an increased risk of infection because the skin is penetrated in two places. However, as the suture-method catheter lumen is only patent at one end, the potential increased risk of infection is entirely due to an additional extraluminal pathway from the exit site. Although colonisation of nerve catheters is frequent, it rarely results in infection [32, 33] even with prolonged use [34] . Careful disinfection before catheter removal might minimise bacterial load [35] .
This study has several limitations. Firstly, we chose to compare MVIC 30 min after local anaesthetic injection with MVIC at baseline for the same leg, and with a control leg for blinding. We therefore conducted a within-group comparison; however, insertion of a catheter per se might reduce MVIC due to pain or discomfort, although none of the volunteers reported any discomfort during comparisons. We have furthermore assessed the influence of catheter insertion post-hoc by comparing MVIC 30 min after injection of placebo with MVIC at baseline in the control group. We found a mean (SD) MVIC of 94% AE 13.9% 30 min after catheter had been injected with placebo compared with baseline. Given that MVIC was reduced in the intervention group to between 0% and 63% of baseline, these results support the hypothesis that the presence of a catheter itself is unlikely to have influenced our results.
Secondly, we did not standardise catheter fixation and this may have affected the displacement rate. Thirdly, testing of cold sensation was inconsistent and it is possible that the tibial component would be less affected than the peroneal component as for MVIC and sEMG and as reported by others [34] . Finally, due to the small number of subjects, there remains some uncertainty related to the estimates for success rate and displacement rate. However, the use of healthy volunteers in this pilot study avoided distinguishing decreased sensory and motor function due to the surgical procedure itself. This makes comparisons with other studies performed in a clinical setting difficult. Specifically, patients would probably be limited in their ability to perform the same extensive physical exercises as we employed, either due to the surgical procedure itself, or because of the sciatic nerve block.
The success rate for placing a suture-method catheter and subsequent displacement in the clinical setting remains to be tested in controlled studies examining patient-relevant outcomes. Future studies could include placing the catheter for a more selective block of the tibial nerve [36] . The use of a parallel approach, placing the catheter alongside the nerve rather than perpendicular to it may also reduce the incidence of displacement [12] . However, the suture-method design enables repositioning of the catheter if necessary [13, 14] , unlike conventional catheter techniques where attempts at repositioning are limited to retraction only.
In conclusion, we have shown that the suturemethod catheter can be placed with high success rates for a sciatic nerve block. Physical exercise may cause displacement, but this will need to be tested further in a clinical setting with standardised methods of fixation. Larger studies comparing the suture-method catheter with other types of catheters are required.
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